Antioxidant trial aims to tame deadly sepsis
NCT ID NCT06661993
Summary
This study tested whether a supplement called alpha-lipoic acid could help people critically ill with sepsis. It involved 80 patients in an Egyptian hospital, who were randomly assigned to receive either the supplement or a placebo for one week. Researchers measured if it reduced organ failure, length of hospital stay, and markers of severe inflammation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Damanhour Teaching Hospital, General Organization for Teaching Hospitals and Institutes.
Damanhūr, Elbehairah, 31527, Egypt
Conditions
Explore the condition pages connected to this study.